378 related articles for article (PubMed ID: 19492488)
1. SSRI antidepressants and persistent pulmonary hypertension in newborns.
Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
Chambers CD; Hernandez-Diaz S; Van Marter LJ; Werler MM; Louik C; Jones KL; Mitchell AA
N Engl J Med; 2006 Feb; 354(6):579-87. PubMed ID: 16467545
[TBL] [Abstract][Full Text] [Related]
5. SSRI antidepressants and birth defects.
Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
[TBL] [Abstract][Full Text] [Related]
6. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
7. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
van der Veere CN; Bos AF
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2873-4. PubMed ID: 18257430
[TBL] [Abstract][Full Text] [Related]
8. SSRI antidepressants: persistent pulmonary hypertension in newborns (continued).
Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189379
[No Abstract] [Full Text] [Related]
9. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
[TBL] [Abstract][Full Text] [Related]
10. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
Bérard A; Sheehy O; Zhao JP; Vinet É; Bernatsky S; Abrahamowicz M
Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine during pregnancy: impact on fetal development.
Morrison JL; Riggs KW; Rurak DW
Reprod Fertil Dev; 2005; 17(6):641-50. PubMed ID: 16263070
[TBL] [Abstract][Full Text] [Related]
12. Safety of newer antidepressants in pregnancy.
Way CM
Pharmacotherapy; 2007 Apr; 27(4):546-52. PubMed ID: 17381382
[TBL] [Abstract][Full Text] [Related]
13. [Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].
Cissoko H; Swortfiguer D; Giraudeau B; Jonville-Béra AP; Autret-Leca E
Arch Pediatr; 2005 Jul; 12(7):1081-4. PubMed ID: 15964522
[TBL] [Abstract][Full Text] [Related]
14. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
[TBL] [Abstract][Full Text] [Related]
15. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
16. The effect of perinatal exposures on the infant: antidepressants and depression.
Hanley GE; Oberlander TF
Best Pract Res Clin Obstet Gynaecol; 2014 Jan; 28(1):37-48. PubMed ID: 24100223
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
[TBL] [Abstract][Full Text] [Related]
18. Maternal use of selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
Alwan S; Bandoli G; Chambers CD
Clin Pharmacol Ther; 2016 Jul; 100(1):34-41. PubMed ID: 27060574
[TBL] [Abstract][Full Text] [Related]
19. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.
Malm H
Ther Drug Monit; 2012 Dec; 34(6):607-14. PubMed ID: 23042258
[TBL] [Abstract][Full Text] [Related]
20. SSRI antidepressants in utero: pulmonary hypertension.
Prescrire Int; 2014 Nov; 23(154):268. PubMed ID: 25954798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
